BRPI0900983A2 - compostos de diometina, processo para sua preparação e composições farmacêuticas contendo os mesmos - Google Patents

compostos de diometina, processo para sua preparação e composições farmacêuticas contendo os mesmos

Info

Publication number
BRPI0900983A2
BRPI0900983A2 BRPI0900983-3A BRPI0900983A BRPI0900983A2 BR PI0900983 A2 BRPI0900983 A2 BR PI0900983A2 BR PI0900983 A BRPI0900983 A BR PI0900983A BR PI0900983 A2 BRPI0900983 A2 BR PI0900983A2
Authority
BR
Brazil
Prior art keywords
compounds
same
diomethine
pharmaceutical compositions
compositions containing
Prior art date
Application number
BRPI0900983-3A
Other languages
English (en)
Inventor
Michel Wierzbicki
Marie-Francoise Boussard
Tony Verbeuren
Patricia Sansilvestri-Morel
Alain Rupin
Jerome Paysant
Francois Lefoulon
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of BRPI0900983A2 publication Critical patent/BRPI0900983A2/pt
Publication of BRPI0900983B1 publication Critical patent/BRPI0900983B1/pt
Publication of BRPI0900983B8 publication Critical patent/BRPI0900983B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)

Abstract

COMPOSTOS DE DIOMETINA, PROCESSO PARA SUA PREPARAçãO E COMPOSIçõES FARMACêUTICAS CONTENDO OS MESMOS. Compostos de fórmula (1): em que R~ 1~, R~ 2~ e R~ 3~, que podem ser iguais ou diferentes, representam, cada um, um átomo de hidrogênio ou o grupo de fórmula (A): Medicamentos.
BRPI0900983A 2008-04-01 2009-03-31 composto de diometina, processo para a síntese do mesmo, composição farmacêutica e seu uso BRPI0900983B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0801779 2008-04-01
FR0801779A FR2929276B1 (fr) 2008-04-01 2008-04-01 Nouveaux derives de diosmetine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
BRPI0900983A2 true BRPI0900983A2 (pt) 2009-11-17
BRPI0900983B1 BRPI0900983B1 (pt) 2020-01-28
BRPI0900983B8 BRPI0900983B8 (pt) 2021-05-25

Family

ID=39809617

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0900983A BRPI0900983B8 (pt) 2008-04-01 2009-03-31 composto de diometina, processo para a síntese do mesmo, composição farmacêutica e seu uso

Country Status (48)

Country Link
US (2) US8138223B2 (pt)
EP (1) EP2107055B1 (pt)
JP (1) JP5047211B2 (pt)
KR (1) KR20120049855A (pt)
CN (1) CN101550124B (pt)
AP (1) AP3024A (pt)
AR (2) AR071120A1 (pt)
AT (1) ATE502024T1 (pt)
AU (1) AU2009201068B2 (pt)
BR (1) BRPI0900983B8 (pt)
CA (1) CA2659947C (pt)
CL (1) CL2009000757A1 (pt)
CO (1) CO6150038A1 (pt)
CR (1) CR10665A (pt)
CU (1) CU23761B7 (pt)
CY (1) CY1111367T1 (pt)
DE (1) DE602009000873D1 (pt)
DK (1) DK2107055T3 (pt)
EA (1) EA015424B1 (pt)
EC (1) ECSP099216A (pt)
ES (1) ES2363196T3 (pt)
FR (1) FR2929276B1 (pt)
GE (1) GEP20115342B (pt)
GT (1) GT200900062A (pt)
HN (1) HN2009000566A (pt)
HR (1) HRP20110361T1 (pt)
IL (1) IL197638A (pt)
JO (1) JO2673B1 (pt)
MA (1) MA31413B1 (pt)
ME (1) MEP10909A (pt)
MX (1) MX2009003383A (pt)
MY (1) MY144726A (pt)
NI (1) NI200900042A (pt)
NZ (1) NZ575902A (pt)
PE (1) PE20091692A1 (pt)
PL (1) PL2107055T3 (pt)
PT (1) PT2107055E (pt)
PY (1) PY09010618A (pt)
RS (1) RS51661B (pt)
SA (1) SA109300201B1 (pt)
SG (1) SG155849A1 (pt)
SI (1) SI2107055T1 (pt)
SV (1) SV2009003199A (pt)
TW (1) TWI385178B (pt)
UA (1) UA98623C2 (pt)
UY (1) UY31712A1 (pt)
WO (1) WO2009133269A1 (pt)
ZA (1) ZA200901947B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2002835A1 (en) 2007-06-04 2008-12-17 GenKyo Tex Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
EP2166009A1 (en) 2008-09-23 2010-03-24 Genkyo Tex Sa Pyrazolo pyridine derivatives as nadph oxidase inhibitors
EP2166010A1 (en) 2008-09-23 2010-03-24 Genkyo Tex Sa Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
EP2165707A1 (en) 2008-09-23 2010-03-24 Genkyo Tex Sa Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
EP2305679A1 (en) 2009-09-28 2011-04-06 GenKyoTex SA Pyrazoline dione derivatives as nadph oxidase inhibitors
FR3002543A1 (fr) * 2013-02-28 2014-08-29 Servier Lab Procede de synthese enzymatique de flavonoides, et application a la synthese de derives de diosmetine
CN106031723A (zh) * 2015-09-29 2016-10-19 西南大学 香叶木素的抗炎活性及其制剂应用
CN106822087A (zh) * 2017-01-12 2017-06-13 西南大学 香叶木素在制备治疗ⅱ型糖尿病的药物中的应用
BR112019023109A2 (pt) * 2017-05-04 2020-05-26 Glenmark Pharmaceuticals S.A. Composto, composição farmacêutica e método para tratar uma doença, distúrbio, síndrome ou afecção mediada por nadph oxidase em um indivíduo
KR102717665B1 (ko) 2017-07-19 2024-10-14 프리머스 파머수티컬즈, 인크. 자가면역 미세혈관 장애의 치료 방법
CN109280067B (zh) * 2017-07-21 2022-07-05 南京正大天晴制药有限公司 香叶木苷衍生物、其制备方法以及医药用途
EP3700334B1 (en) * 2017-10-27 2026-04-08 Immunebridge Inc. Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene
EP3479843A1 (en) 2017-11-01 2019-05-08 GenKyoTex Suisse SA Use of nox inhibitors for treatment of cancer
CN109394753B (zh) * 2018-12-24 2020-10-02 武汉轻工大学 香叶木素在制备预防和/或治疗高尿酸血症肾病的药物中的应用
CN120570881B (zh) * 2025-06-04 2026-05-19 上海市中西医结合医院 千层纸素a的医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701261B1 (fr) * 1993-02-05 1995-03-31 Adir Nouveaux composés glucuronides de la diosmétine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
FR2726273B1 (fr) * 1994-10-26 1996-12-06 Adir Nouveaux derives de la diosmetine, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2748025B1 (fr) * 1996-04-25 1998-10-30 Adir Nouveaux acides et esters de la diosmetine, et les compositions pharmaceutiques les contenant
EP1063235B1 (en) * 1998-03-12 2004-05-12 Teijin Limited Benzofurylpyrone derivatives
GB9920912D0 (en) * 1999-09-03 1999-11-10 Indena Spa Novel derivatives of flavones,xanthones and coumarins
FR2882654B1 (fr) * 2005-03-01 2007-04-27 Servier Lab Utilisation de derives de la diosmetine pour le traitement et la prevention des pathologies thrombotiques

Also Published As

Publication number Publication date
EA015424B1 (ru) 2011-08-30
NI200900042A (es) 2010-03-19
FR2929276A1 (fr) 2009-10-02
BRPI0900983B1 (pt) 2020-01-28
ATE502024T1 (de) 2011-04-15
TWI385178B (zh) 2013-02-11
CU23761B7 (es) 2012-01-31
CU20090048A7 (es) 2011-03-21
SG155849A1 (en) 2009-10-29
US20090247621A1 (en) 2009-10-01
CA2659947C (fr) 2012-05-08
ME00680B (me) 2011-12-20
ZA200901947B (en) 2010-02-24
KR20120049855A (ko) 2012-05-17
AR109739A2 (es) 2019-01-16
CO6150038A1 (es) 2010-04-20
AR071120A1 (es) 2010-05-26
CN101550124B (zh) 2011-11-30
SI2107055T1 (sl) 2011-05-31
JP2009263354A (ja) 2009-11-12
AU2009201068A1 (en) 2009-10-15
EA200900397A1 (ru) 2010-10-29
JP5047211B2 (ja) 2012-10-10
NZ575902A (en) 2010-12-24
PE20091692A1 (es) 2009-11-07
MA31413B1 (fr) 2010-06-01
FR2929276B1 (fr) 2010-04-23
IL197638A (en) 2014-06-30
GT200900062A (es) 2011-10-13
MX2009003383A (es) 2009-10-16
PY09010618A (es) 2014-09-01
HRP20110361T1 (hr) 2011-06-30
EP2107055B1 (fr) 2011-03-16
CY1111367T1 (el) 2015-08-05
IL197638A0 (en) 2009-12-24
DE602009000873D1 (de) 2011-04-28
AU2009201068B2 (en) 2012-11-22
HK1136291A1 (en) 2010-06-25
SV2009003199A (es) 2009-10-27
AP2009004810A0 (en) 2009-04-30
MY144726A (en) 2011-10-31
US8404742B2 (en) 2013-03-26
WO2009133269A1 (fr) 2009-11-05
ES2363196T3 (es) 2011-07-26
US8138223B2 (en) 2012-03-20
UY31712A1 (es) 2009-05-29
UA98623C2 (ru) 2012-06-11
PL2107055T3 (pl) 2011-06-30
BRPI0900983B8 (pt) 2021-05-25
RS51661B (sr) 2011-10-31
JO2673B1 (en) 2012-06-17
GEP20115342B (en) 2011-12-12
PT2107055E (pt) 2011-05-09
CR10665A (es) 2009-05-25
MEP10909A (xx) 2011-12-20
ECSP099216A (es) 2010-03-31
CN101550124A (zh) 2009-10-07
DK2107055T3 (da) 2011-06-27
US20120208777A1 (en) 2012-08-16
AP3024A (en) 2014-11-30
TW200944539A (en) 2009-11-01
SA109300201B1 (ar) 2013-04-20
CL2009000757A1 (es) 2010-03-26
CA2659947A1 (fr) 2009-10-01
EP2107055A1 (fr) 2009-10-07
HN2009000566A (es) 2011-07-11

Similar Documents

Publication Publication Date Title
BRPI0900983B8 (pt) composto de diometina, processo para a síntese do mesmo, composição farmacêutica e seu uso
BRPI0712631A8 (pt) compostos, processos para a preparação de um composto, composição farmacêutica, uso de um composto e combinações
BRPI0607455A2 (pt) composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
BRPI1005940A2 (pt) processo para preparar compostos de 2-nitrobifenila de fórmula i, compostos de 2-aminobifenila de fórmula vi, n-acil-2-aminobifenilas da fórmula geral (vii), composto de fórmula i, composto de fórmula ii, composto de fórmula iii e composto de fórmula x.1 ou x.2
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
BRPI0813284A8 (pt) Processo para a preparação de um composto da fórmula (i) e composto
BR112012027509A8 (pt) Composto pirazolil-quinoxalina inibidor de quinase, combinação, produto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, e método
EA201170772A1 (ru) Органические соединения
BR112012032244A2 (pt) processo para preparar derivados de antranilamida com tetrazole-substituído e polimorfos cristalinos novos e derivados destes
BRPI0612957B8 (pt) composto, processos de preparação de compostos, composição farmacêutica e uso de um composto
BR112012009214A2 (pt) compostos
BRPI0817242A2 (pt) Composto derivado de 1,1,1-trifluoro -2-hidroxi-3-fenilpropano, processo para a sua manufatura, composição farmacêuticas que os contêm, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de glicocorticóides e uso de tais compostos
BRPI0719281B8 (pt) processo para preparação de nebivolol
BRPI0916069B8 (pt) composto, usos de um composto e composição farmacêutica
BRPI0816911A8 (pt) Processo para preparação de 4-aminobut-2-enolidas
SE0401762D0 (sv) Novel compounds
WO2008034142A3 (en) Synthesis, methods of using, and compositions of cycloalkylmethylamines
BRPI0518203A2 (pt) mÉtodos para preparaÇço de compostos indazol
BRPI0909737A2 (pt) compostos de pirrolidinila, composição farmacêutica compreendendo os mesmos e usos dos mesmos
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
BRPI0511722A (pt) 3-amino-1-arilpropilindóis como inibidores da recaptação de monoamina
BR112013003121A2 (pt) moduladores de trpv3
BR112012021944A2 (pt) novos agentes de cura
BRPI0512986A (pt) novos derivados de hidantoìna
UY29510A1 (es) Derivados de urea, metodos para su fabricación, y usos de los mismos

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 28/01/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 31/03/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2873 DE 27-01-2026 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.